DOI: 10.12890/2022_003658

Berardinelli-Seip Congenital Lipodystrophy Discovered Following a STEMI Event

Authors

  • Francisca Beires Department of Internal Medicine, Hospital Pedro Hispano, Senhora da Hora, Portugal
  • Helena Greenfield Department of Internal Medicine, Hospital Pedro Hispano, Senhora da Hora, Portugal 0000-0003-1876-3164
  • José Brito da Silva Department of Medical Oncology, Instituto Português de Oncologia do Porto FG, EPE, Porto, Portugal 0000-0002-0181-5354
  • João Gil Department of Internal Medicine, Hospital Pedro Hispano, Senhora da Hora, Portugal 0000-0001-9381-7682
  • Nuno Moreno Department of Cardiology, Hospital Pedro Hispano, Senhora da Hora, Portugal 0000-0003-1410-4057

beires.francisca@gmail.com

Keywords

Berardinelli-Seip, myocardial infarction, familial lipodystrophy, thrombocytosis, triglycerides

Abstract

A 60-year-old man, with a history of familial lipodystrophy, hypertriglyceridaemia, hepatic steatosis and bone cysts, was admitted due an acute coronary event. Coronary angiography showed significant stenosis in the left anterior descending artery, which was treated. Transthoracic echocardiography showed a slightly dilated left ventricle with diffuse and heterogeneous thickening of its walls, slightly decreased left ventricular function and reduced global longitudinal strain. Due to these echocardiographic findings, cardiac magnetic resonance imaging was requested, which identified intramyocardial diffuse fibrosis of the basal septum and points of insertion of the left and right ventricles, without oedema, microvascular obstruction or myocardial infarction. Owing to the constellation of symptoms and distinctive features on cardiac imaging, a diagnosis of Berardinelli-Seip congenital lipodystrophy (BSCL) was suspected, which was confirmed through genetic testing of the pathogenic variants in BSCL2 and AGPAT2. BSCL is a rare autosomal recessive syndrome characterized by the congenital absence of adipose tissue and triglyceride deposition in other tissues, such as muscle, liver and heart. 

View the entire article

Downloads

References

  1. Alzu'bi AA, Al-Sarihin KK, Eteiwi S, Al-Asaad RA, Al Eyadah AA, Khreisat M, et al. Berardinelli-Seip syndrome and essential thrombocytosis: an unusual association. Oman Med J 2020;35(3):e135. doi: 10.5001/omj.2020.53
  2. Van Maldergem L. Berardinelli-Seip congenital lipodystrophy. GeneReviews 8 September 2003 (updated 8 December 2016).
  3. Araujo-Vilar D, Sánchez-Iglesias S, Guillín-Amarelle C, Castro A, Lage M, Pazos M, et al. Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience. Endocrine 2015;49:139–147. https://doi.org/10.1007/s12020-014-0450-4
  4. Viégas RF, Diniz RV, Viégas TM, Lira EB, Almeida DR. Cardiac involvement in total generalized lipodystrophy (Berardinelli-Seip syndrome). Arq Bras Cardiol 2000;75(3):243–248.
  5. Romano MMD, Chacon PAI, Ramalho FNZ, Foss MC, Schmidt A. Cardiac alterations in patients with familial lipodystrophy. Arq Bras Cardiol 2020;114(2):305–312.

Published

2022-12-14

Issue

Vol. 9 No. 12 (2022)

How to Cite

1.
Beires F, Helena Greenfield, José Brito da Silva, João Gil, Nuno Moreno. Berardinelli-Seip Congenital Lipodystrophy Discovered Following a STEMI Event. EJCRIM [Internet]. 2022 Dec. 14 [cited 2026 Nov. 3];9(12). Available from: https://ejcrim.com/index.php/ejcrim/article/view/3658

Most read articles by the same author(s)